• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Hoth Therapeutics Inc (NQ: HOTH )

    1.190 -0.020 (-1.65%)
    Streaming Delayed Price Updated: 3:48 PM EDT, May 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 16,922
    Open 1.215
    Bid (Size) 1.180 (1)
    Ask (Size) 1.200 (1)
    Prev. Close 1.210
    Today's Range 1.170 - 1.230
    52wk Range 0.9900 - 4.300
    Shares Outstanding 23,873,626
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. 
    Via Benzinga
    Why Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?
    Hoth Therapeutics reveals preclinical findings on HT-ALZ, a potential Alzheimer's therapeutic targeting the Substance P/Neurokinin 1 Receptor pathway. HT-ALZ exhibits significant reductions in soluble... 
    Via Benzinga

    Performance

    YTD
    -17.94%
    -17.94%
    1 Month
    -15.00%
    -15.00%
    3 Month
    -11.85%
    -11.85%
    6 Month
    -2.46%
    -2.46%
    1 Year
    -30.41%
    -30.41%

    More News

    Read More
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    EF Hutton Maintains Buy Rating for Hoth Therapeutics: Here's What You Need To Know
    Via Benzinga
    Analyst Expectations for Hoth Therapeutics's Future
    Via Benzinga
    Hoth Therapeutics Stock Almost Doubles in Tuesday's Trading Session, Here's Why
    Via Benzinga
    Why Hoth Therapeutics Shares Are Rising Today
    Via Benzinga
    Hoth Therapeutics' Investigational Cancer Drug Shows Encouraging Preclinical Activity In Stomach Cancers
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Hoth Therapeutics Alzheimer's Treatment Shows Improvement In Cognitive Function, Anxiety
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Fear & Greed Index Moves To 'Extreme Greed' Zone After US Stocks Settle Higher
    Via Benzinga
    Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
    Via Benzinga
    Stocks Mixed As VIX Extends Lows
    Via Talk Markets
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Hoth Therapeutics Inc. (NASDAQ: HOTH) Near Top of Volume Charts in Tuesday Trading
    Via Investor Brand Network
    Nasdaq Edges Higher; Joann Shares Plummet
    Via Benzinga
    Why Is Hoth Therapeutics (HOTH) Stock Up 83% Today?
    Via InvestorPlace
    Benzinga Pro's Top 5 Stocks To Watch For Tuesday, June 6, 2023: AAPL, DIS, COIN, GME, HOTH
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.